172 related articles for article (PubMed ID: 27573001)
1. The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.
Yamaguchi M
Mol Cell Biochem; 2016 Oct; 421(1-2):193-203. PubMed ID: 27573001
[TBL] [Abstract][Full Text] [Related]
2. The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro: Implications for suppression of bone metastases.
Yamaguchi M; Murata T; Shoji M; Weitzmann MN
Int J Oncol; 2015 Oct; 47(4):1563-71. PubMed ID: 26238204
[TBL] [Abstract][Full Text] [Related]
3. Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis.
Yamaguchi M
Yakugaku Zasshi; 2006 Nov; 126(11):1117-37. PubMed ID: 17077614
[TBL] [Abstract][Full Text] [Related]
4. Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis.
Yamaguchi M; Zhu S; Zhang S; Wu D; Moore TM; Snyder JP; Shoji M
Cell Tissue Res; 2014 Jul; 357(1):245-52. PubMed ID: 24723227
[TBL] [Abstract][Full Text] [Related]
5. Phytocomponent p-hydroxycinnamic acid stimulates bone formation and inhibits bone resorption in rat femoral tissues in vitro.
Lai YL; Yamaguchi M
Mol Cell Biochem; 2006 Nov; 292(1-2):45-52. PubMed ID: 17036165
[TBL] [Abstract][Full Text] [Related]
6. Bioactive flavonoid p-hydroxycinnamic acid stimulates osteoblastogenesis and suppresses adipogenesis in bone marrow culture.
Yamaguchi M; Baile CA; Zhu S; Shoji M
Cell Tissue Res; 2013 Dec; 354(3):743-50. PubMed ID: 24026435
[TBL] [Abstract][Full Text] [Related]
7. The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro.
Yamaguchi M; Murata T; Ramos JW
J Cancer Res Clin Oncol; 2021 Feb; 147(2):339-350. PubMed ID: 33001270
[TBL] [Abstract][Full Text] [Related]
8. Role of carotenoid β-cryptoxanthin in bone homeostasis.
Yamaguchi M
J Biomed Sci; 2012 Apr; 19(1):36. PubMed ID: 22471523
[TBL] [Abstract][Full Text] [Related]
9. Curcumin analog UBS109 prevents bone marrow osteoblastogenesis and osteoclastogenesis disordered by coculture with breast cancer MDA-MB-231 bone metastatic cells in vitro.
Yamaguchi M; Zhu S; Weitzmann MN; Snyder JP; Shoji M
Mol Cell Biochem; 2015 Mar; 401(1-2):1-10. PubMed ID: 25416449
[TBL] [Abstract][Full Text] [Related]
10. The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 Sep; 30(3):708-12. PubMed ID: 22751682
[TBL] [Abstract][Full Text] [Related]
11. Nutritional factors and bone homeostasis: synergistic effect with zinc and genistein in osteogenesis.
Yamaguchi M
Mol Cell Biochem; 2012 Jul; 366(1-2):201-21. PubMed ID: 22476903
[TBL] [Abstract][Full Text] [Related]
12. Phytocomponent p-hydroxycinnamic acid stimulates mineralization in osteoblastic MC3T3-E1 cells.
Yamaguchi M; Lai YL; Uchiyama S; Nakagawa T
Int J Mol Med; 2008 Sep; 22(3):287-91. PubMed ID: 18698486
[TBL] [Abstract][Full Text] [Related]
13. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
[TBL] [Abstract][Full Text] [Related]
14. Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition.
Yamaguchi M; Moore TW; Sun A; Snyder JP; Shoji M
Integr Biol (Camb); 2012 Aug; 4(8):905-13. PubMed ID: 22751853
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity.
Keller ET; Brown J
J Cell Biochem; 2004 Mar; 91(4):718-29. PubMed ID: 14991763
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of breast cancer metastases to bone.
Guise TA; Kozlow WM; Heras-Herzig A; Padalecki SS; Yin JJ; Chirgwin JM
Clin Breast Cancer; 2005 Feb; 5 Suppl(2):S46-53. PubMed ID: 15807924
[TBL] [Abstract][Full Text] [Related]
17. β-Caryophyllene promotes osteoblastic mineralization, and suppresses osteoclastogenesis and adipogenesis in mouse bone marrow cultures
Yamaguchi M; Levy RM
Exp Ther Med; 2016 Dec; 12(6):3602-3606. PubMed ID: 28105093
[TBL] [Abstract][Full Text] [Related]
18. Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases.
Strazic-Geljic I; Guberovic I; Didak B; Schmid-Antomarchi H; Schmid-Alliana A; Boukhechba F; Bouler JM; Scimeca JC; Verron E
Biochem Pharmacol; 2016 Sep; 116():11-21. PubMed ID: 27378505
[TBL] [Abstract][Full Text] [Related]
19. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
[TBL] [Abstract][Full Text] [Related]
20. Coordinate regulatory osteogenesis effects of icariin, timosaponin B II and ferulic acid from traditional Chinese medicine formulas on UMR-106 osteoblastic cells and osteoblasts in neonatal rat calvaria cultures.
Li M; Zhang ND; Wang Y; Han T; Jiang YP; Rahman K; Qin LP; Xin HL; Zhang QY
J Ethnopharmacol; 2016 Jun; 185():120-31. PubMed ID: 26983755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
